Skip to main content
Top
Published in: BMC Geriatrics 1/2018

Open Access 01-12-2018 | Research article

The OptimaMed intervention to reduce inappropriate medications in nursing home residents with severe dementia: results from a quasi-experimental feasibility pilot study

Authors: Machelle Wilchesky, Gerhard Mueller, Michèle Morin, Martine Marcotte, Philippe Voyer, Michèle Aubin, Pierre-Hugues Carmichael, Nathalie Champoux, Johanne Monette, Anik Giguère, Pierre Durand, René Verreault, Marcel Arcand, Edeltraut Kröger

Published in: BMC Geriatrics | Issue 1/2018

Login to get access

Abstract

Background

Medication regimens in nursing home (NH) residents with severe dementia should be frequently reviewed to avoid inappropriate medication, overtreatment and adverse drug events, within a comfort care approach. This study aimed at testing the feasibility of an interdisciplinary knowledge exchange (KE) intervention using a medication review guidance tool categorizing medications as either “generally”, “sometimes” or “exceptionally” appropriate for NH residents with severe dementia.

Methods

A quasi-experimental feasibility pilot study with 44 participating residents aged 65 years or over with severe dementia was carried out in three NH in Quebec City, Canada. The intervention comprised an information leaflet for residents’ families, a 90-min KE session for NH general practitioners (GP), pharmacists and nurses focusing on the medication review guidance tool, a medication review by the pharmacists for participating residents with ensuing team discussion on medication changes, and a post-intervention KE session to obtain feedback from team staff. Medication regimens and levels of pain and of agitation of the participants were evaluated at baseline and at 4 months post-intervention. A questionnaire for team staff explored perceived barriers and facilitators. Statistical differences in measures comparing pre and post-intervention were assessed using paired t-tests and Cochran’s-Q tests.

Results

The KE sessions reached 34 NH team staff (5 GP, 4 pharmacists, 6 heads of care unit and 19 staff nurses). Forty-four residents participated in the study and were followed for a mean of 104 days. The total number of regular medications was 372 pre and 327 post-intervention. The mean number of regular medications per resident was 7.86 pre and 6.81 post-intervention. The odds ratios estimating the risks of using any regular medication or a “sometimes appropriate” medication post-intervention were 0.81 (95% CI: 0.71–0.92) and 0.83 (95% CI: 0.74–0.94), respectively.

Conclusion

A simple KE intervention using a medication review guidance tool categorizing medications as being either “generally”, “sometimes” or “exceptionally” appropriate in severe dementia was well received and accompanied by an overall reduction in medication use by NH residents with severe dementia. Levels of agitation were unaffected and there was no clinically significant changes in levels of pain. Staff feedback provided opportunities to improve the intervention.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.CrossRefPubMedPubMedCentral Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.CrossRefPubMedPubMedCentral
2.
go back to reference Lee SP, Bain KT, Maio V. Appropriate discontinuation of medications at the end of life: a need to establish consensus criteria. Am J Med Qual. 2007;22(6):393–4.CrossRefPubMed Lee SP, Bain KT, Maio V. Appropriate discontinuation of medications at the end of life: a need to establish consensus criteria. Am J Med Qual. 2007;22(6):393–4.CrossRefPubMed
3.
go back to reference Holmes HM. Rational prescribing for patients with a reduced life expectancy. Clin Pharmacol Ther. 2009;85(1):103–7.CrossRefPubMed Holmes HM. Rational prescribing for patients with a reduced life expectancy. Clin Pharmacol Ther. 2009;85(1):103–7.CrossRefPubMed
4.
5.
go back to reference Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107–16.CrossRefPubMed Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107–16.CrossRefPubMed
6.
go back to reference Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging. 2005;22(9):767–77.CrossRefPubMed Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging. 2005;22(9):767–77.CrossRefPubMed
7.
go back to reference Hanlon JT, Pieper CF, Hajjar ER, Sloane RJ, Lindblad CI, Ruby CM, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci. 2006;61(5):511–5.CrossRefPubMed Hanlon JT, Pieper CF, Hajjar ER, Sloane RJ, Lindblad CI, Ruby CM, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci. 2006;61(5):511–5.CrossRefPubMed
8.
go back to reference Olivier P, Bertrand L, Tubery M, Lauque D, Montastruc JL, Lapeyre-Mestre M. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs Aging. 2009;26(6):475–82.CrossRefPubMed Olivier P, Bertrand L, Tubery M, Lauque D, Montastruc JL, Lapeyre-Mestre M. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs Aging. 2009;26(6):475–82.CrossRefPubMed
9.
go back to reference Fahlman C, Lynn J, Finch M, Doberman D, Gabel J. Potentially inappropriate medication use by Medicaid+choice beneficiaries in the last year of life. J Palliat Med. 2007;10(3):686–95.CrossRefPubMed Fahlman C, Lynn J, Finch M, Doberman D, Gabel J. Potentially inappropriate medication use by Medicaid+choice beneficiaries in the last year of life. J Palliat Med. 2007;10(3):686–95.CrossRefPubMed
10.
go back to reference Gallagher P, Barry P, O'Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32(2):113–21.CrossRefPubMed Gallagher P, Barry P, O'Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32(2):113–21.CrossRefPubMed
11.
go back to reference Canadian Institute for Health Information. Drug Use Among Seniors on Public Drug Programs in Canada, 2012. Ottawa: CIHI; 2014. Canadian Institute for Health Information. Drug Use Among Seniors on Public Drug Programs in Canada, 2012. Ottawa: CIHI; 2014.
12.
go back to reference Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med. 2001;135(8 Pt 2):703–10.CrossRefPubMed Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med. 2001;135(8 Pt 2):703–10.CrossRefPubMed
13.
go back to reference Brauner DJ, Muir JC, Sachs GA. Treating nondementia illnesses in patients with dementia. JAMA. 2000;283(24):3230–5.CrossRefPubMed Brauner DJ, Muir JC, Sachs GA. Treating nondementia illnesses in patients with dementia. JAMA. 2000;283(24):3230–5.CrossRefPubMed
14.
go back to reference Lau DT, Mercaldo ND, Harris AT, Trittschuh E, Shega J, Weintraub S. Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord. 2010;24(1):56–63.CrossRefPubMedPubMedCentral Lau DT, Mercaldo ND, Harris AT, Trittschuh E, Shega J, Weintraub S. Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord. 2010;24(1):56–63.CrossRefPubMedPubMedCentral
15.
go back to reference Toscani F, Di Giulio P, Villani D, Giunco F, Brunelli C, Gentile S, et al. Treatments and prescriptions in advanced dementia patients residing in long-term care institutions and at home. J Palliat Med. 2013;16(1):31–7.CrossRefPubMed Toscani F, Di Giulio P, Villani D, Giunco F, Brunelli C, Gentile S, et al. Treatments and prescriptions in advanced dementia patients residing in long-term care institutions and at home. J Palliat Med. 2013;16(1):31–7.CrossRefPubMed
16.
go back to reference Tjia J, Cutrona SL, Peterson D, Reed G, Andrade SE, Mitchell SL. Statin discontinuation in nursing home residents with advanced dementia. J Am Geriatr Soc. 2014;62(11):2095–101.CrossRefPubMedPubMedCentral Tjia J, Cutrona SL, Peterson D, Reed G, Andrade SE, Mitchell SL. Statin discontinuation in nursing home residents with advanced dementia. J Am Geriatr Soc. 2014;62(11):2095–101.CrossRefPubMedPubMedCentral
17.
go back to reference Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293(11):1348–58.CrossRefPubMed Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293(11):1348–58.CrossRefPubMed
18.
go back to reference Blass DM, Black BS, Phillips H, Finucane T, Baker A, Loreck D, et al. Medication use in nursing home residents with advanced dementia. Int J Geriatr Psychiatry. 2008;23(5):490–6.CrossRefPubMed Blass DM, Black BS, Phillips H, Finucane T, Baker A, Loreck D, et al. Medication use in nursing home residents with advanced dementia. Int J Geriatr Psychiatry. 2008;23(5):490–6.CrossRefPubMed
19.
go back to reference American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63(11):2227–46.CrossRef American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63(11):2227–46.CrossRef
20.
go back to reference O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.CrossRefPubMed O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.CrossRefPubMed
21.
go back to reference Arcand M, Roy-Petit J, Voyer G, Allard J, Ethier S. Doit-on prescrire des médicaments à visée préventive dans un contexte de démence modérée ou grave? La revue de gériatrie. 2007;32(3 Mars):189–200. Arcand M, Roy-Petit J, Voyer G, Allard J, Ethier S. Doit-on prescrire des médicaments à visée préventive dans un contexte de démence modérée ou grave? La revue de gériatrie. 2007;32(3 Mars):189–200.
22.
go back to reference Holmes HM, Sachs GA, Shega JW, Hougham GW, Cox Hayley D, Dale W. Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc. 2008;56(7):1306–11.CrossRefPubMed Holmes HM, Sachs GA, Shega JW, Hougham GW, Cox Hayley D, Dale W. Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc. 2008;56(7):1306–11.CrossRefPubMed
23.
go back to reference Kroger E, Wilchesky M, Marcotte M, Voyer P, Morin M, Champoux N, et al. Medication use among nursing home residents with severe dementia: identifying categories of appropriateness and elements of a successful intervention. J Am Med Dir Assoc. 2015;16(7):629 e1–17. Kroger E, Wilchesky M, Marcotte M, Voyer P, Morin M, Champoux N, et al. Medication use among nursing home residents with severe dementia: identifying categories of appropriateness and elements of a successful intervention. J Am Med Dir Assoc. 2015;16(7):629 e1–17.
24.
go back to reference Dubuc N, Hebert R, Desrosiers J, Buteau M, Trottier L. Disability-based classification system for older people in integrated long-term care services: the Iso-SMAF profiles. Arch Gerontol Geriatr. 2006;42(2):191–206.CrossRefPubMed Dubuc N, Hebert R, Desrosiers J, Buteau M, Trottier L. Disability-based classification system for older people in integrated long-term care services: the Iso-SMAF profiles. Arch Gerontol Geriatr. 2006;42(2):191–206.CrossRefPubMed
25.
go back to reference Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull. 1988;24(4):653–9.PubMed Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull. 1988;24(4):653–9.PubMed
26.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
28.
go back to reference Fuchs-Lacelle S, Hadjistavropoulos T, Lix L. Pain assessment as intervention: a study of older adults with severe dementia. Clin J Pain. 2008;24(8):697–707.CrossRefPubMed Fuchs-Lacelle S, Hadjistavropoulos T, Lix L. Pain assessment as intervention: a study of older adults with severe dementia. Clin J Pain. 2008;24(8):697–707.CrossRefPubMed
29.
go back to reference Aubin M, Verreault R, Savoie M, LeMay S, Hadjistavropoulos T, Fillion L, et al. [Validity 'and Utilities' clinic of a grid observation (PACSLAC-F) to evaluate the pain in seniors with dementia's living in the Long-Term Care ]. Can J Aging. 2008 Spring;27(1):45–55. Aubin M, Verreault R, Savoie M, LeMay S, Hadjistavropoulos T, Fillion L, et al. [Validity 'and Utilities' clinic of a grid observation (PACSLAC-F) to evaluate the pain in seniors with dementia's living in the Long-Term Care ]. Can J Aging. 2008 Spring;27(1):45–55.
30.
go back to reference Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. J Gerontol. 1989;44(3):M77–84.CrossRefPubMed Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. J Gerontol. 1989;44(3):M77–84.CrossRefPubMed
31.
go back to reference Deslauriers S, Landreville P, Dicaire L, Verreault R. Validité et fidélité de l'Inventaire d'agitation de Cohen-Mansfield. Can J Aging. 2001;20(3):374–84.CrossRef Deslauriers S, Landreville P, Dicaire L, Verreault R. Validité et fidélité de l'Inventaire d'agitation de Cohen-Mansfield. Can J Aging. 2001;20(3):374–84.CrossRef
32.
go back to reference Arcand M, Monette J, Monette M, Sourial N, Fournier L, Gore B, et al. Educating nursing home staff about the progression of dementia and the comfort care option: impact on family satisfaction with end-of-life care. J Am Med Dir Assoc. 2009;10(1):50–5.CrossRefPubMed Arcand M, Monette J, Monette M, Sourial N, Fournier L, Gore B, et al. Educating nursing home staff about the progression of dementia and the comfort care option: impact on family satisfaction with end-of-life care. J Am Med Dir Assoc. 2009;10(1):50–5.CrossRefPubMed
33.
go back to reference Arcand M, Verreault R. Améliorer les soins de fin de vie en démence avancée. Ger Psychol Neuropsychiatr Vieil. 2014;12(suppl 1):37. Arcand M, Verreault R. Améliorer les soins de fin de vie en démence avancée. Ger Psychol Neuropsychiatr Vieil. 2014;12(suppl 1):37.
34.
go back to reference van der Steen JT, Radbruch L, Hertogh CM, de Boer ME, Hughes JC, Larkin P, et al. White paper defining optimal palliative care in older people with dementia: a Delphi study and recommendations from the European Association for Palliative Care. Palliat Med. 2014;28(3):197–209.CrossRefPubMed van der Steen JT, Radbruch L, Hertogh CM, de Boer ME, Hughes JC, Larkin P, et al. White paper defining optimal palliative care in older people with dementia: a Delphi study and recommendations from the European Association for Palliative Care. Palliat Med. 2014;28(3):197–209.CrossRefPubMed
35.
go back to reference Reisberg B, Ferris SH, de Leon MJ, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136–39.CrossRefPubMed Reisberg B, Ferris SH, de Leon MJ, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136–39.CrossRefPubMed
37.
go back to reference Ballard CG, Gauthier S, Cummings JL, Brodaty H, Grossberg GT, Robert P, et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol. 2009;5(5):245–55.CrossRefPubMed Ballard CG, Gauthier S, Cummings JL, Brodaty H, Grossberg GT, Robert P, et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol. 2009;5(5):245–55.CrossRefPubMed
38.
go back to reference Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146(11):775–86.CrossRefPubMed Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146(11):775–86.CrossRefPubMed
39.
go back to reference Rochon PA, Normand SL, Gomes T, Gill SS, Anderson GM, Melo M, et al. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med. 2008;168(10):1090–6.CrossRefPubMed Rochon PA, Normand SL, Gomes T, Gill SS, Anderson GM, Melo M, et al. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med. 2008;168(10):1090–6.CrossRefPubMed
40.
go back to reference Monette J, Monette M, Sourial N, Vandal AC, Wolfson C, Champoux N, et al. Effect of an interdisciplinary educational program on antipsychotic prescribing among residents with dementia in two long-term care centers. J Appl Gerontol. 2013;32(7):833–54.CrossRefPubMed Monette J, Monette M, Sourial N, Vandal AC, Wolfson C, Champoux N, et al. Effect of an interdisciplinary educational program on antipsychotic prescribing among residents with dementia in two long-term care centers. J Appl Gerontol. 2013;32(7):833–54.CrossRefPubMed
41.
go back to reference Ballard C, Lana MM, Theodoulou M, Douglas S, McShane R, Jacoby R, et al. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Med. 2008;5(4):587–99.CrossRef Ballard C, Lana MM, Theodoulou M, Douglas S, McShane R, Jacoby R, et al. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Med. 2008;5(4):587–99.CrossRef
42.
go back to reference Pan YJ, Wu CS, Gau SS, Chan HY, Banerjee S. Antipsychotic discontinuation in patients with dementia: a systematic review and meta-analysis of published randomized controlled studies. Dement Geriatr Cogn Disord. 2014;37(3–4):125–40.CrossRefPubMed Pan YJ, Wu CS, Gau SS, Chan HY, Banerjee S. Antipsychotic discontinuation in patients with dementia: a systematic review and meta-analysis of published randomized controlled studies. Dement Geriatr Cogn Disord. 2014;37(3–4):125–40.CrossRefPubMed
43.
go back to reference Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline. Can Fam Physician. 2018;64(1):17–27.PubMedPubMedCentral Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline. Can Fam Physician. 2018;64(1):17–27.PubMedPubMedCentral
44.
go back to reference Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890–8.CrossRefPubMed Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890–8.CrossRefPubMed
45.
go back to reference Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging. 2008;25(12):1021–31.CrossRefPubMed Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging. 2008;25(12):1021–31.CrossRefPubMed
46.
go back to reference Garfinkel D. Poly-de-prescribing to treat polypharmacy: efficacy and safety. Ther Adv Durg Saf. 2017:1–19. Garfinkel D. Poly-de-prescribing to treat polypharmacy: efficacy and safety. Ther Adv Durg Saf. 2017:1–19.
48.
go back to reference Wouters H, Scheper J, Koning H, Brouwer C, Twisk JW, van der Meer H, et al. Discontinuing inappropriate medication use in nursing home residents. A cluster randomized controlled trial. Ann Intern Med. 2017;167(9):609–17.CrossRefPubMed Wouters H, Scheper J, Koning H, Brouwer C, Twisk JW, van der Meer H, et al. Discontinuing inappropriate medication use in nursing home residents. A cluster randomized controlled trial. Ann Intern Med. 2017;167(9):609–17.CrossRefPubMed
49.
go back to reference Gallagher P, O'Mahony D. STOPP (screening tool of older Persons' potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing. 2008;37(6):673–9.CrossRefPubMed Gallagher P, O'Mahony D. STOPP (screening tool of older Persons' potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing. 2008;37(6):673–9.CrossRefPubMed
50.
go back to reference Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89(6):845–54.CrossRefPubMed Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89(6):845–54.CrossRefPubMed
51.
go back to reference Reeve E, Low LF, Hilmer SN. Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study. Br J Gen Pract. 2016;66(649):e552–60.CrossRefPubMedPubMedCentral Reeve E, Low LF, Hilmer SN. Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study. Br J Gen Pract. 2016;66(649):e552–60.CrossRefPubMedPubMedCentral
52.
go back to reference Turner JP, Edwards S, Stanners M, Shakib S, Bell JS. What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals. BMJ Open. 2016;6(3):e009781.CrossRefPubMedPubMedCentral Turner JP, Edwards S, Stanners M, Shakib S, Bell JS. What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals. BMJ Open. 2016;6(3):e009781.CrossRefPubMedPubMedCentral
53.
go back to reference Simard M, Marcotte M, Pluye P, Sirois C, Champoux N, Arcand M, et al. Chapitre 13 : Attitudes et comportements des aînés et de leurs proches face à la polypharmacie ou à la déprescription: une revue mixte de la littérature. In: Bujold M, QN Hong, V Ridde, CJ Bourque, MJ Dogba, I Vedel et P Pluye, editors. Oser les défis des méthodes mixtes en sciences sociales et sciences de la santé. Cahiers scientifiques de l'ACFAS. Montréal, Canada: ACFAS; 2018. p. 223–43. Simard M, Marcotte M, Pluye P, Sirois C, Champoux N, Arcand M, et al. Chapitre 13 : Attitudes et comportements des aînés et de leurs proches face à la polypharmacie ou à la déprescription: une revue mixte de la littérature. In: Bujold M, QN Hong, V Ridde, CJ Bourque, MJ Dogba, I Vedel et P Pluye, editors. Oser les défis des méthodes mixtes en sciences sociales et sciences de la santé. Cahiers scientifiques de l'ACFAS. Montréal, Canada: ACFAS; 2018. p. 223–43.
Metadata
Title
The OptimaMed intervention to reduce inappropriate medications in nursing home residents with severe dementia: results from a quasi-experimental feasibility pilot study
Authors
Machelle Wilchesky
Gerhard Mueller
Michèle Morin
Martine Marcotte
Philippe Voyer
Michèle Aubin
Pierre-Hugues Carmichael
Nathalie Champoux
Johanne Monette
Anik Giguère
Pierre Durand
René Verreault
Marcel Arcand
Edeltraut Kröger
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2018
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-018-0895-z

Other articles of this Issue 1/2018

BMC Geriatrics 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine